Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY) Q3 2026 Earnings

30JulConfirmed

Q4 2025

Q1 2026

Q2 2026

Q3 2026

0.56

0.99

1.41

1.84

Details

Expected EPS

1.630186

Actual EPS

1.21

Surprise EPS

-0.42

Surprise Percent

+25.78%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of 1.21 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.